Positive 12-month Phase 2 data for NDV-01 in non-muscle invasive bladder cancer (NMIBC) demonstrated a 95% complete response (CR) rate at any ...

As a potential biomarker of treatment response, ctDNA and utDNA analyses were performed before systemic therapy, at restaging, and for responders at the beginning of adjuvant nivolumab. ctDNA was ...

One in ten patients who attend A&E after noticing blood in their urine die within three months, new research has revealed.

Getting a timely scan within 48 hours for accident and emergency patients with blood in urine (hematuria) speeds up bladder cancer diagnosis and significantly saves lives.

Photocure ASA (OSE: PHO), the Bladder Cancer Company, announces two "trial in progress" presentations at the 2026 European Association ...

ONE in 10 A&E patients who complain of a common bladder cancer symptom die within just three months, concerning research suggests. Bladder cancer is one of the most common cancers in ...

Dr. Alexandre Zlotta delivered the State-of-the-art lecture Who really needs surgery after neo-adjuvant chemotherapy? Dr.

Bladder Pain Syndrome is believed to arise from bladder wall hypersensitivity and disruption of its protective lining, ...

For over a year, Suzannah Weiss lived with unrelenting pain. After being dismissed by eight doctors, specialized testing ...

The authors have declared no conflicts of interest. The patient provided informed consent for the publication of this case report. Acknowledgements: Gupta was involved in writing the original draft, ...

It is used both to treat tumours and to help clinicians determine whether they are cancerous, as well as their grade and ...

Durable 76% complete response (CR) rate at 12 months with 95% CR rate at any time in high-risk NMIBCBCG-unresponsive patients achieved an 80% CR rate at 12 months and 94% CR rate at any time ...